3-iodobenzylguanidine has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, A; Franco, A; Katzman, PJ | 1 |
| Admiraal, WM; Bahler, L; Hoekstra, JB; Holleman, F; Soeters, MR; Stok, WJ; Verberne, HJ | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Obesity
| Article | Year |
|---|---|
Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Contrast Media; Developmental Disabilities; Diagnosis, Differential; Female; Fingers; Humans; Infant, Newborn; Intellectual Disability; Liver Neoplasms; Magnetic Resonance Imaging; Microcephaly; Muscle Hypotonia; Myopia; Neoplasm Staging; Neuroblastoma; Obesity; Organometallic Compounds; Retinal Degeneration; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2018 |
Differences in Sympathetic Nervous Stimulation of Brown Adipose Tissue Between the Young and Old, and the Lean and Obese.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adult; Aging; Body Weight; Cold Temperature; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Obesity; Overweight; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sympathetic Nervous System; Waist Circumference; Young Adult | 2016 |